Temporal Changes in Obesity-Related Medication After Bariatric Surgery vs No Surgery for Obesity.

ABSTRACT:

Importance

Bariatric surgery can resolve hyperlipidemia, cardiovascular disease, and diabetes, but the long-term postoperative trajectories of medications for these conditions are unknown.

Objective

To clarify the long-term use of lipid-lowering, cardiovascular, and antidiabetic medication after bariatric surgery compared with no surgery for morbid obesity.

Design, setting, and participants

This population-based cohort study took place in Sweden (2005-2020) and Finland (1995-2018) and included individuals diagnosed with obesity. Analysis took place between July 2021 and January 2022.

Exposures

Bariatric surgery (gastric bypass or sleeve gastrectomy) patients using lipid-lowering, cardiovascular, or antidiabetic medication were compared with 5 times as many cont

SUBMITTER: Kauppila JH 

PROVIDER: S-EPMC10209832 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature